Patricia B. Lehane
Welwyn Garden City, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis.
Journal: Clinical and translational science
Published: May 17, 2022
Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis.
Journal: Rheumatology and therapy
Published: December 14, 2021
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
Journal: The New England journal of medicine
Published: June 07, 2021
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 03, 2020
Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis.
Journal: Arthritis care & research
Published: November 20, 2019
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data.
Journal: Rheumatology and therapy
Published: September 03, 2019
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.
Journal: The British journal of dermatology
Published: August 29, 2019
Correction to: Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
Journal: Journal of neurovirology
Published: April 11, 2018
Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
Journal: Journal of neurovirology
Published: November 30, 2017
Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years.
Journal: The Journal of rheumatology
Published: June 17, 2015
Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: July 31, 2014
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients.
Journal: Annals of the rheumatic diseases
Published: November 09, 2012
Last Updated: 09/26/2026